Physician profile
Paul Chacko
NPI 1932253200
$28,366.28
in general payments reported to CMS, 2019-2025
34 companies · $8,762 in 2025
The $8,762 reported for 2025 was more than what 78% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,989 · 2020: $3,109 · 2021: $8,538 · 2022: $2,053 · 2023: $1,713 · 2024: $2,203 · 2025: $8,762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,490 · Travel and Lodging: $5,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,490.20 |
| Travel and Lodging | $5,188.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,844.45 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Cobalt Dr Mri Surescan |
| Sanofi-Aventis U.S. LLC | $3,926.78 | 2021 | |
| Boston Scientific Corporation | $3,666.20 | 2019-2025 | Ingevity+, Farapulse, Rhythmia Mapping System |
| Biotronik INC. | $3,479.65 | 2019-2025 | Selectra, Solia, Acticor 7 Vr-T Dx |
| Biosense Webster, INC. | $3,317.51 | 2019-2025 | Carto 3, Soundstar, Nuvision Ice Catheter |
| Abbott Laboratories | $2,232.35 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $604.70 | 2019-2023 | Camzyos |
| Philips North America LLC | $504.37 | 2019-2025 | Ecc Solutions, (Ao0) Igt Devices Intracardiac |
| Cardiofocus, INC. | $501.54 | 2022 | |
| Atricure, INC. | $454.82 | 2022-2024 | |
| Medtronic Vascular, INC. | $429.08 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $328.87 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $295.64 | 2023-2024 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $287.79 | 2021-2022 | |
| Cardiva Medical, INC. | $226.09 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anumana, INC. | $156.97 | 2025 | Ecg-Ai Lef |
| Impulse Dynamics (USA) INC. | $151.22 | 2022 | |
| Penumbra, INC. | $125.00 | 2021 | |
| Preventice Services, LLC | $123.73 | 2019-2021 | |
| Amgen INC. | $104.10 | 2019-2022 | |
| Merit Medical Systems INC | $83.18 | 2020 | |
| Haemonetics Corporation | $81.25 | 2024 | Ensoetm |
| Abiomed | $78.73 | 2023 | Impella |
| Cordis US Corp. | $76.06 | 2025 | Mynx Control Venous |
| Inari Medical, INC. | $58.23 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.88 | 2023-2025 | Lifevest |
| Cook Medical LLC | $42.85 | 2020 | |
| Heartflow, INC. | $38.54 | 2024 | |
| Novartis Pharmaceuticals Corporation | $30.62 | 2019 | |
| Lilly USA, LLC | $21.51 | 2021 | |
| Smith+Nephew, INC. | $14.55 | 2023 | Grafix |
| Amarin Pharma, INC. | $13.30 | 2021 | |
| Pfizer INC. | $11.72 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Chacko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.